{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T22:41:59Z","timestamp":1784500919211,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T00:00:00Z","timestamp":1728172800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.idnow.2023.104780","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:48:55Z","timestamp":1694760535000},"page":"104780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["The principles of curative antibiotic treatments"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6151-0686","authenticated-orcid":false,"given":"Robert","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Grimprel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2898-3710","authenticated-orcid":false,"given":"Alexis","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Hau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6816-5272","authenticated-orcid":false,"given":"Fouad","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Ouldali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4274-9795","authenticated-orcid":false,"given":"Josette","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10325","key":"10.1016\/j.idnow.2023.104780_b0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.idnow.2023.104780_b0010","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Cited 18 July 2023. Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf."},{"key":"10.1016\/j.idnow.2023.104780_b0015","unstructured":"Groupe de pathologie infectieuse p\u00e9diatrique (GPIP). Guide de prescription d'antibiotiques en p\u00e9diatrie. Cited 17 July 2023. Available from: https:\/\/gpip.sfpediatrie.com\/sites\/sfp-specialites.02.prod.cyim.com\/files\/documents\/arcped_gpip_15_juin_new_couv_bs_0.pdf."},{"key":"10.1016\/j.idnow.2023.104780_b0020","unstructured":"Haute autorit\u00e9 de sant\u00e9. Choix et dur\u00e9es d\u2019antibioth\u00e9rapie pr\u00e9conis\u00e9es dans les infections bact\u00e9riennes courantes. Cited 18 July 2023. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-08\/reco360_synthese_durees_antibiotherapies_coi_2021_07_15_v2.pdf."},{"key":"10.1016\/j.idnow.2023.104780_b0025","unstructured":"Infectious diseases society of America. IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Cited 18 July 2023. Available from: https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/."},{"issue":"4","key":"10.1016\/j.idnow.2023.104780_b0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.idnow.2023.104780_b0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.inf.0000239271.10784.1e","article-title":"Approaches to reduce antibiotic resistance in the community","volume":"25","author":"Cohen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.idnow.2023.104780_b0040","unstructured":"World health organization, 2021 AWaRe classification. Cited 17 July 2023. Available from: https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification."},{"key":"10.1016\/j.idnow.2023.104780_b0045","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise. Actualisation de la liste des antibiotiques critiques disponibles en france pour l'exercice lib\u00e9ral et en \u00e9tablissements de sant\u00e9. Cited 17 July 2023. Available from: https:\/\/www.infectiologie.com\/fr\/actualites\/antibiotiques-critiques-disponibles-en-france_-n.html."},{"key":"10.1016\/j.idnow.2023.104780_b0050","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise. Antibiotherapie par voie generale en pratique courante dans les infections respiratoires hautes de l\u2019adulte et l\u2019enfant. Cited 17 July 2023. Available from: https:\/\/www.infectiologie.com\/UserFiles\/File\/medias\/Recos\/2011-infections-respir-hautes-recommandations.pdf."},{"key":"10.1016\/j.idnow.2023.104780_b0055","unstructured":"Haute autorit\u00e9 de sant\u00e9. Choix et dur\u00e9e de l'antibioth\u00e9rapie : otite moyenne aigu\u00eb purulente de l\u2019enfant. Cited 17 July 2023. Available from: https:\/\/www.has-sante.fr\/jcms\/c_2722749\/fr\/choix-et-duree-de-l-antibiotherapie-otite-moyenne-aigue-purulente-de-l-enfant."},{"key":"10.1016\/j.idnow.2023.104780_b0060","unstructured":"European medicines agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. Cited 17 July 2023. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf."},{"key":"10.1016\/j.idnow.2023.104780_b0065","unstructured":"Centers for disease control and prevention. Research on doxycycline and tooth staining. Cited 17 July 2023. Available from: https:\/\/www.cdc.gov\/rmsf\/doxycycline\/index.html."},{"key":"10.1016\/j.idnow.2023.104780_b0070","first-page":"CD003038","article-title":"Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia","volume":"6","author":"Paul","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.idnow.2023.104780_b0075","first-page":"355","article-title":"Allergy to penicillin in children: what reality and when to give up amoxicillin ?","volume":"68","author":"Ouldali","year":"2018","journal-title":"Rev Prat."},{"key":"10.1016\/j.idnow.2023.104780_b0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.idnow.2020.12.001","article-title":"Anti-infectious treatment duration: the SPILF and GPIP French guidelines and recommendations","volume":"51","author":"Gauzit","year":"2021","journal-title":"Infect Dis Now"},{"issue":"8","key":"10.1016\/j.idnow.2023.104780_b0085","first-page":"2344","article-title":"Community antibiotic prescribing for children in France from 2015 to 2017: a cross-sectional national study","volume":"75","author":"Trinh","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idnow.2023.104780_b0090","doi-asserted-by":"crossref","first-page":"e035343","DOI":"10.1136\/bmjopen-2019-035343","article-title":"Clinical practice guidelines for acute otitis media in children: a systematic review and appraisal of European national guidelines","volume":"10","author":"Suzuki","year":"2020","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.idnow.2023.104780_b0095","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00431-014-2395-2","article-title":"Streptococcal pharyngitis in children: to treat or not to treat?","volume":"173","author":"Van Brusselen","year":"2014","journal-title":"Eur J Pediatr"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991923001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991923001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:33:12Z","timestamp":1763019192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991923001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666991923001422"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2023.104780","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The principles of curative antibiotic treatments","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2023.104780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104780"}}